Psychemedics Company Overview

Psychemedics  logo
Psychemedics
Psychemedics  primary media

About Psychemedics

Psychemedics (NASDAQ:PMD) specializes in drug testing services with a focus on hair analysis, offering solutions for employers, law enforcement agencies, schools, and individuals seeking to detect drug use. The company is known for its rigorous testing methodologies which are designed to uncover drug consumption over a longer period compared to traditional urine tests. Psychemedics' projects range from developing new testing panels for emerging drugs to enhancing the sensitivity and specificity of its current tests. The company's main objective is to provide accurate, reliable drug testing solutions that can aid in creating safer, drug-free environments across various sectors. By continuously investing in research and development, Psychemedics aims to stay at the forefront of drug testing technology, addressing new challenges in substance abuse detection.

What is Psychemedics known for?

Snapshot

1986
Year founded
133
Employees
Acton, United States
Head office
Loading Map...

Operations

All Locations
United States

Products and/or services of Psychemedics

  • Hair Drug Testing Services for detecting drug abuse by analyzing hair samples, offering accurate and longer detection periods.
  • Workplace Drug Testing to help employers maintain a drug-free environment and adhere to regulatory compliance.
  • Court-Ordered Drug Testing providing legal and forensic hair drug testing for child custody, probation, and other legal cases.
  • Personal Drug Testing Services for individuals seeking private and confidential drug testing solutions.
  • Global Testing Solutions tailored to meet the specific drug testing requirements of international clients and regulatory environments.
  • Educational Institution Drug Testing programs designed to support schools and universities in maintaining a safe and drug-free educational setting.

Psychemedics executive team

  • Mr. Brian HullingerPresident, CEO & Director
  • Ms. Daniella MehalikVice President of Finance
  • Ms. Shannon ShoemakerVP & Chief Revenue Officer
  • Dr. Werner A. Baumgartner Ph.D.Founder
  • Ms. Annette BaumgartnerFounder
  • Mr. Michael WeisenhoffPrincipal Financial & Accounting Manager
  • Mr. Patrick J. Kinney Jr.Secretary

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.